Uwe Schneider
Papers
3
Total Citations
78
H-Index
2
About
Uwe Schneider is a leading researcher in radiation oncology and space radiobiology, whose work bridges the critical gap between terrestrial cancer treatment and the unique challenges of human space exploration. His primary research areas include stereotactic body radiotherapy (SBRT) for pelvic and prostate cancers, advanced treatment planning for robotic and O‑Ring linear accelerators, and the quantification of radiation risks for long‑duration space missions. Schneider’s most impactful contribution is his landmark 2023 paper, “Towards sustainable human space exploration—priorities for radiation research to quantify and mitigate radiation risks,” which has already garnered 63 citations and outlines a strategic roadmap for protecting astronauts on Moon and Mars missions. In the clinical domain, he has advanced prostate cancer radiotherapy by studying intra‑fractional motion during CyberKnife® treatments and by developing quality assessment criteria for automated SBRT plans targeting pelvic lymph node metastases. His work on establishing minimum target volume thresholds for O‑Ring linac plans provides practical guidance for clinicians. Through this dual focus on terrestrial oncology and space radiation protection, Schneider is shaping both the future of precision cancer therapy and the safety of human exploration beyond Earth.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3